Diltiazem Hydrochloride
Product Images NDC 66336-669

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 66336-669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4789cec5-figure-01 (4789cec5 Figure 01)

FDA Label Image

4789cec5-figure-02 (4789cec5 Figure 02)

FDA Label Image

4789cec5-figure-03 (4789cec5 Figure 03)

FDA Label Image

4789cec5-figure-04 (4789cec5 Figure 04)

FDA Label Image

4789cec5-figure-05 (4789cec5 Figure 05)

FDA Label Image

Ndc 66336-0669-xx (Ndc 66336 0669 Xx Actavis)

Ndc 66336-0669-xx (Ndc 66336 0669 Xx      Actavis)
This is a medication label for Diltiazem CD 240mg extended-release capsules containing instructions for use, storage, and warnings. It includes the manufacturer, product ID, pedigree number, and lot number. The medication is dispensed in a tight/light-resistant container and should be taken orally once a day, swallowed whole, and not chewed, divided, or discontinued without physician's advice. It may cause dizziness, drowsiness, or headache. It also emphasizes to keep the medication out of children's reach and store it at 77°F.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.